Signal detection

Identifying sources of potential harm to patients is UMC’s highest priority. Detecting and communicating signals of such harm lies at the heart of pharmacovigilance.

Detecting signals

Signal detection aims to identify and describe suspected harm to patients, caused by their use of medicines. The evidence comes primarily in the form of spontaneous reports from health professionals across the world, from pharmaceutical companies and some from patients. Signal detection is a core UMC activity.

What is a signal?

Signal detection at UMC

With the unique resource of VigiBase, signal detection is a top priority for UMC's multidisciplinary team.

UMC's signal detection process

Caveat Document

Issues relating to the tentative nature of data underlying signals and to data protection matters

Read the Caveat document here


Review panel

Meet the experts who support the UMC's signal detection process

Read more and view the list

Communicating signals

UMC regularly communicates its signals to national pharmacovigilance centres around the world.

Read more SIGNAL library